ZGOO Holdings Co. Ltd.
KKRX:2218003,585.00
KRW
+50.00
(+1.41%)
ISIN
KR7221800006
Return %
Stock
S&P 500
1Y
2.72
13.14
3Y
- -
80.78
5Y
- -
67.74
Capital Structure
KRW
•
in mil. unless spec.Working Capital
KRW
•
in mil. unless spec.Growth Rates
KRW
•
in mil. unless spec.Quarterly Revenue
KRW
•
in mil. unless spec.Quarterly Earnings Per Share
KRW
•
in mil. unless spec.Quarterly Dividends Per Share
KRW
•
in mil. unless spec.Company Description
- CEO
- Sang-Wook Park
- Full Time Employees
- 98
- Sector
- Health services
- Industry
- Medical/Nursing services
- Address
- Seoul South Korea
- IPO Date
- Jun 29, 2015
- Website
- zgoo.xyz
- Similar Companies
- Business
- ZGOO Holdings Co. Ltd., formerly known as U2Bio Co. Ltd., is a South Korea-based investment holding company engaged in venture management, healthcare information technology (IT) solutions, in-vitro diagnostics (IVD), clinical laboratory testing services, and digital platform technologies. The company provides a comprehensive suite of products and services across multiple operating segments: clinical laboratory and diagnostic testing services, comprising molecular diagnostics, genomic analysis, cytopathology, infectious disease testing, and routine biochemical sample examination for healthcare institutions; in-vitro diagnostic products and reagents, including the U2Plex series of molecular diagnostic assay kits, alpha-thalassemia screening kits, and real-time PCR diagnostic systems; medical IT and laboratory software solutions, featuring Laboratory Information Systems (LIS) for diagnostic data automation, U2Gateway interface middleware connecting medical laboratory analyzers with electronic medical record (EMR) systems, U2SmartQC for quality control and laboratory compliance, and U2Check for health screening management; mobile and digital healthcare applications, including the HealthWallet personal health record (PHR) mobile platform, appointment scheduling, and automated patient test result notification services; and artificial intelligence and interactive digital entertainment technologies. Founded in 2009 and headquartered in Seoul, South Korea, ZGOO Holdings serves hospitals, medical clinics, research organizations, and digital consumers primarily in South Korea and select overseas markets. In recent corporate developments, the company executed a major corporate restructuring and physical division in March 2026, transitioning to a venture holding company structure operating under a permanent capital model and changing its corporate name from U2Bio Co. Ltd. to ZGOO Holdings Co. Ltd. As part of the spin-off, its in-vitro diagnostics and medical IT operational units were transferred to a newly established operating subsidiary, U2Bio Co. Ltd., while ZGOO Holdings maintains its public listing on the KOSDAQ market (KRX: 221800) to oversee strategic investments and group governance. In August 2026, Lee Jae-woong, founder of Daum Communications and former CEO of Socar, became the company's largest shareholder and assumed the role of Chief Executive Officer. To diversify and scale its technology portfolio, ZGOO Holdings acquired a 51.8% controlling equity interest in Neural Arcade Co. Ltd., an artificial intelligence and social interactive platform developer.